Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Seewaldt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of General Microbiology|August 1, 1981
A phylogenetic analysis of staphylococci, Peptococcus saccharolyticus and Micrococcus mucilaginosusW Ludwig, K H Schleifer, G E Fox, et al.
Journal of Cardiovascular Pharmacology|August 1, 1997
Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivoB D Guth, E Seewaldt-Becker, F Himmelsbach, et al.
Diabetes, Obesity & Metabolism|February 13, 2013
A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetesE Ferrannini, L Seman, E Seewaldt-Becker, et al.
Diabetes, Obesity & Metabolism|January 30, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetesT Heise, E Seewaldt-Becker, S Macha, et al.
Journal of General Microbiology|March 1, 1985
The phylogenetic position of Streptococcus and EnterococcusW Ludwig, E Seewaldt, R Kilpper-Bälz, et al.
Elife|November 15, 2024
Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibilityRosalyn W Sayaman, Masaru Miyano, Eric G Carlson, et al.
Nature Aging|February 21, 2022
Evidence for accelerated aging in mammary epithelia of women carrying germline <i>BRCA1</i> or <i>BRCA2</i> mutationsSundus F Shalabi, Masaru Miyano, Rosalyn W Sayaman, et al.
Ebiomedicine|April 24, 2026
MechanoAge, a machine learning platform to identify individuals susceptible to breast cancer based on mechanical properties of single cellsStefan Hinz, Sturla M Grøndal, Masaru Miyano, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
MechanoAge, a machine learning platform to identify individuals susceptible to breast cancer based on mechanical properties of single cellsStefan Hinz, Sturla M Grøndal, Masaru Miyano, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of General Microbiology|August 1, 1981
A phylogenetic analysis of staphylococci, Peptococcus saccharolyticus and Micrococcus mucilaginosusW Ludwig, K H Schleifer, G E Fox, et al.
Journal of Cardiovascular Pharmacology|August 1, 1997
Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivoB D Guth, E Seewaldt-Becker, F Himmelsbach, et al.
Diabetes, Obesity & Metabolism|February 13, 2013
A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetesE Ferrannini, L Seman, E Seewaldt-Becker, et al.
Diabetes, Obesity & Metabolism|January 30, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetesT Heise, E Seewaldt-Becker, S Macha, et al.
Journal of General Microbiology|March 1, 1985
The phylogenetic position of Streptococcus and EnterococcusW Ludwig, E Seewaldt, R Kilpper-Bälz, et al.
Elife|November 15, 2024
Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibilityRosalyn W Sayaman, Masaru Miyano, Eric G Carlson, et al.
Nature Aging|February 21, 2022
Evidence for accelerated aging in mammary epithelia of women carrying germline <i>BRCA1</i> or <i>BRCA2</i> mutationsSundus F Shalabi, Masaru Miyano, Rosalyn W Sayaman, et al.
Ebiomedicine|April 24, 2026
MechanoAge, a machine learning platform to identify individuals susceptible to breast cancer based on mechanical properties of single cellsStefan Hinz, Sturla M Grøndal, Masaru Miyano, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
MechanoAge, a machine learning platform to identify individuals susceptible to breast cancer based on mechanical properties of single cellsStefan Hinz, Sturla M Grøndal, Masaru Miyano, et al.
Pageof 1